We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current MYX market cap is 615.09M. The company's latest EPS is AUD -2.0480 and P/E is -3.53.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 456.99M | 400.78M | 400.93M | 262.48M | 386.19M |
| Operating Income | -104.12M | -230.15M | -11.86M | -233.15M | -171.6M |
| Net Income | -92.79M | -208.42M | -281.29M | 117.25M | -174.23M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 1.83B | 1.46B | 1.29B | 1.25B | 1.14B |
| Total Liabilities | 782.87M | 691.61M | 749.7M | 612.99M | 688.99M |
| Total Equity | 1.04B | 771.58M | 538.23M | 634.36M | 454.19M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | 99.78M | 58.86M | -7.21M | -42.71M | -15.3M |
| Investing | -55.87M | -49.25M | -28.53M | 473.49M | 53.45M |
| Financing | 4.52M | -40.44M | 27.6M | -431.89M | -19.85M |
| Market Cap | 615.09M |
| Price to Earnings Ratio | -3.53 |
| Price to Sales Ratio | 1.59 |
| Price to Cash Ratio | 5.59 |
| Price to Book Ratio | 1.35 |
| Dividend Yield | - |
| Shares Outstanding | 85.07M |
| Average Volume (1 week) | 751.46k |
| Average Volume (1 Month) | 969.01k |
| 52 Week Change | 4.03% |
| 52 Week High | 7.46 |
| 52 Week Low | 3.74 |
| Spread (Intraday) | -0.58 (-8.27%) |
| Company Name | Mayne Pharma Group Ltd |
| Address |
1538 main north road adelaide, south australia 5106 |
| Website | https://www.maynepharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
